DERM

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Peers: EBS PTCT ANAB RVNC IRWD CAPR CDTX AVDL ATNM MNOV

| Held by: VTI IWM VXF IWO VTWO IWC VTWG RSSL DFAC DFSU

Index	RUT	P/E	-	EPS (ttm)	-0.39	Insider Own	61.16%	Shs Outstand	17.47M	Perf Week	1.57%
Market Cap	187.33M	Forward P/E	10.53	EPS next Y	0.68	Insider Trans	-0.07%	Shs Float	10.22M	Perf Month	-1.93%
Enterprise Value	192.32M	PEG	-	EPS next Q	-0.03	Inst Own	24.55%	Short Float	13.70%	Perf Quarter	5.01%
Income	-8.74M	P/S	3.32	EPS this Y	56.11%	Inst Trans	41.67%	Short Ratio	8.13	Perf Half Y	35.62%
Sales	56.40M	P/B	8.68	EPS next Y	313.92%	ROA	-11.94%	Short Interest	1.40M	Perf YTD	82.10%
Book/sh	0.82	P/C	9.23	EPS next 5Y	-	ROE	-57.22%	52W High	8.90 -20.00%	Perf Year	48.64%
Cash/sh	0.77	P/FCF	-	EPS past 3/5Y	34.37% -	ROIC	-21.48%	52W Low	3.54 101.41%	Perf 3Y	145.52%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-3.84% 9.96%	Gross Margin	59.57%	Volatility	4.68% 4.33%	Perf 5Y	-
Dividend TTM	-	EV/Sales	3.41	EPS Y/Y TTM	-475.41%	Oper. Margin	-20.24%	ATR (14)	0.34	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.95	Sales Y/Y TTM	-27.40%	Profit Margin	-15.49%	RSI (14)	47.42	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.27	EPS Q/Q	3.03%	SMA20	-1.03%	Beta	0.80	Target Price	11.80
Payout	-	Debt/Eq	1.31	Sales Q/Q	1.04%	SMA50	-2.23%	Rel Volume	0.51	Prev Close	7.11
Employees	41	LT Debt/Eq	1.11	Earnings	Aug 12 AMC	SMA200	15.36%	Avg Volume	172.27K	Price	7.12
IPO	Nov 12, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	-52.38% 1.47%	Trades		Volume	87,353	Change	0.14%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-25-25	Initiated	H.C. Wainwright	Buy	$13
Jul-30-25	Resumed	B. Riley Securities	Buy	$12
Aug-22-24	Initiated	Rodman & Renshaw	Buy	$9
Jun-28-24	Resumed	ROTH MKM	Buy	$11
Dec-07-21	Initiated	B. Riley Securities	Buy	$14

Sep-04-25 08:06AM	New Strong Sell Stocks for September 4th (Zacks)
Sep-03-25 08:30AM	Journey Medical Corporation to Participate in September 2025 Investor Conferences (GlobeNewswire)
Aug-18-25 08:30AM	Journey Medical Corporation to Present at the Emerging Growth Conference (GlobeNewswire)
Aug-13-25 07:00PM	Journey Medical Corp (DERM) Q2 2025 Earnings Call Highlights: Strong Arosi Launch Drives ... (GuruFocus.com) -15.11%
Aug-12-25 05:15PM	Journey Medical Corporation (DERM) Reports Q2 Loss, Beats Revenue Estimates (Zacks) +8.51%
04:01PM	Loading…
04:01PM	Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Aug-11-25 09:36AM	Journey Medical Corp (DERM) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
09:10AM	3 Biotech Stocks Likely to Outpace Q2 Earnings Estimates (Zacks)
Aug-07-25 08:30AM	Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11 (GlobeNewswire)
Aug-05-25 04:01PM	Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025 (GlobeNewswire)
Aug-04-25 10:00AM	Journey Medical Corporation (DERM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release (Zacks)
Jul-14-25 08:30AM	Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi (GlobeNewswire)
Jun-24-25 08:30AM	Journey Medical to Join Russell 2000 and Russell 3000 Indexes (GlobeNewswire) +8.93%
Jun-21-25 08:35AM	Journey Medical announces data analysis from Phase 3 trials of Emrosi (TipRanks)
Jun-20-25 08:30AM	Journey Medical Corporation Announces Emrosi Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference (GlobeNewswire)
08:30AM	Loading…
Jun-09-25 08:30AM	Journey Medical Corporation Announces Emrosi Featured on "The Balancing Act" Airing on Lifetime TV (GlobeNewswire)
May-15-25 07:01PM	Journey Medical Corp (DERM) Q1 2025 Earnings Call Highlights: Amrosi Launch Boosts Margins ... (GuruFocus.com) +18.93%
04:05PM	Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights (GlobeNewswire)
May-14-25 05:10PM	Journey Medical Corporation (DERM) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -5.54%
04:01PM	Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights (GlobeNewswire)
May-13-25 09:41AM	What To Expect From Journey Medical Corp (DERM) Q1 2025 Earnings (GuruFocus.com) -7.47%
May-12-25 07:10AM	Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
May-08-25 06:15PM	The Joint Corp. (JYNT) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-07-25 04:01PM	Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025 (GlobeNewswire) +6.92%
May-06-25 05:20PM	Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Lags Revenue Estimates (Zacks) -5.39%
May-05-25 09:57AM	Strength Seen in Profound Medical (PROF): Can Its 8.3% Jump Turn into More Strength? (Zacks)
Apr-30-25 05:25AM	Why Journey Medical Corporation (DERM) is Surging in 2025 (Insider Monkey)
Apr-23-25 07:00AM	Journey Medical (DERM) Moves 16.8% Higher: Will This Strength Last? (Zacks)
Apr-18-25 05:46PM	Is Journey Medical Corporation (DERM) a Cheap Hot Stock to Buy Right Now? (Insider Monkey)
Apr-07-25 09:17AM	Journey Medical (DERM) Surges 9.1%: Is This an Indication of Further Gains? (Zacks)
04:01PM	Loading…
Apr-01-25 04:01PM	Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer (GlobeNewswire)
Mar-31-25 04:05PM	Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Mar-27-25 08:25AM	Q4 2024 Journey Medical Corp Earnings Call (Thomson Reuters StreetEvents)
03:02AM	Journey Medical Corp (DERM) Q4 2024 Earnings Call Highlights: Strategic Launch of Emrosi and ... (GuruFocus.com)
Mar-26-25 07:10PM	Journey Medical Corporation (DERM) Q4 2024 Earnings Call Transcript (SeekingAlpha) -5.25%
05:15PM	Journey Medical Corporation (DERM) Tops Q4 Earnings Estimates (Zacks)
04:01PM	Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Mar-25-25 09:04AM	Journey Medical Corp (DERM) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
08:50AM	Journey Medical launches Emrosi for the treatment of rosacea (TipRanks)
Mar-24-25 08:30AM	Journey Medical Corporation Launches Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea (GlobeNewswire) +13.94%
Mar-19-25 04:01PM	Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025 (GlobeNewswire) +7.88%
Mar-12-25 08:30AM	Journey Medical Corporation to Participate in the 37th Annual ROTH Conference (GlobeNewswire)
Mar-05-25 04:01PM	Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi (DFD-29) to Treat Rosacea (GlobeNewswire)
Mar-04-25 04:01PM	Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida (GlobeNewswire)
Feb-20-25 02:38PM	Journey Medical Corporation (DERM): A Bull Case Theory (Insider Monkey)
Jan-24-25 08:57AM	Minot Light Capitals Largest Performance Detractor in Q4: Journey Medical (DERM) (Insider Monkey) +8.05%
Jan-23-25 08:30AM	Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea (GlobeNewswire)
Nov-14-24 04:10PM	Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Nov-12-24 05:25PM	Journey Medical Corporation (DERM) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -6.06%
04:01PM	Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Nov-05-24 11:29AM	FDA approves Journey Medicals rosacea treatment Emrosi (Pharmaceutical Technology)
Nov-04-24 07:18AM	Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock? (Zacks) -13.78%
07:00AM	Journey Medical Corporation Announces U.S. FDA Approval of Emrosi (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea (GlobeNewswire)
Oct-25-24 08:30AM	Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference (GlobeNewswire) +6.27%
Oct-17-24 04:15PM	SWK Holdings Provides Portfolio Update (ACCESSWIRE)
Oct-03-24 08:30AM	Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference (GlobeNewswire)
Sep-09-24 08:30AM	Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference (GlobeNewswire)
Sep-04-24 08:15AM	Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire)
Aug-13-24 04:05PM	Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire) +14.22%
Aug-12-24 05:10PM	Journey Medical Corporation (DERM) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -15.26%
04:01PM	Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Aug-06-24 04:01PM	Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024 (GlobeNewswire)
Jul-17-24 04:15PM	SWK Holdings Highlights Recent Achievements and Provides Portfolio Update (ACCESSWIRE)
Jul-11-24 04:05PM	Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors (GlobeNewswire)
May-15-24 04:15PM	Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire)
04:01PM	Journey Medical Corporation to Participate in the Alliance Global Partners' (A.G.P.) Virtual Healthcare Company Showcase (GlobeNewswire)
May-14-24 03:07AM	Journey Medical Corp (DERM) (Q1 2024) Earnings Call Transcript Highlights: Navigating Growth ... (GuruFocus.com)
May-13-24 08:55PM	DERM Stock Earnings: Journey Medical Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
04:01PM	Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire)
May-07-24 08:30AM	Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024 (GlobeNewswire)
May-01-24 04:01PM	Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer (GlobeNewswire)
Apr-29-24 09:00AM	Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-25-24 08:30AM	Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024 (GlobeNewswire)
Mar-28-24 04:05PM	Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire) -5.40% -10.05%
Mar-25-24 07:01PM	Director Justin Smith Acquires 30,000 Shares of Journey Medical Corp (DERM) (GuruFocus.com) -11.52% +26.37%
Mar-22-24 06:01AM	Q4 2023 Journey Medical Corp Earnings Call (Thomson Reuters StreetEvents) -13.61%
Mar-21-24 09:53PM	DERM Stock Earnings: Journey Medical Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace)
04:01PM	Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Mar-19-24 08:49AM	Journey Medical (DERM) Up as FDA Accepts Skin Disease Drug NDA (Zacks)
Mar-18-24 08:30AM	Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea (GlobeNewswire) +10.00%
Mar-15-24 08:30AM	Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024 (GlobeNewswire)
Mar-13-24 08:30AM	Journey Medical Corporation to Participate in the 36th Annual ROTH Conference (GlobeNewswire)
Mar-11-24 08:30AM	Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting (GlobeNewswire)
Feb-26-24 11:35AM	Journey Medical (DERM) to Report Q4 Earnings: What's in the Cards? (Zacks)
Jan-05-24 08:30AM	Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea (GlobeNewswire)
Jan-02-24 04:05PM	Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million (GlobeNewswire) -5.73% -8.29%
Dec-27-23 08:50AM	Here's What Could Help Journey Medical Corporation (DERM) Maintain Its Recent Price Strength (Zacks)
Dec-13-23 08:09AM	Is it a Good Idea to Buy Journey Medical (DERM) Stock Now? (Zacks)
Dec-07-23 09:16AM	Journey Medical (DERM) Up on Update for Skin Disease Candidate (Zacks) +9.69%
Dec-06-23 08:00AM	Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea (GlobeNewswire) +6.10%
Nov-30-23 12:00PM	Are You Looking for a Top Momentum Pick? Why Journey Medical Corporation (DERM) is a Great Choice (Zacks) +5.43%
Nov-29-23 08:50AM	What Makes Journey Medical Corporation (DERM) a Good Fit for 'Trend Investing' (Zacks) -25.00%
Nov-14-23 04:10PM	Fortress Biotech Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Nov-12-23 09:36AM	Journey Medical Corporation (NASDAQ:DERM) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 04:01PM	Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire) +5.54% +9.62%
Nov-01-23 08:00AM	Jasper Therapeutics Announces Appointment of Thomas G. Wiggans as Chairperson of the Board of Directors (GlobeNewswire)
Oct-31-23 08:30AM	Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023 (GlobeNewswire) +5.94%
Oct-20-23 08:30AM	Journey Medical Corporation Announces Data from Bioavailability Study of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) vs. Solodyn (Minocycline Hydrochloride Extended-Release Tablets, 105 mg) (GlobeNewswire) +8.33%
Sep-09-23 01:04AM	Insider Buying: Journey Medical Corp's President & CEO Claude Maraoui Acquires 26,044 Shares (GuruFocus.com)
Sep-07-23 11:45AM	Journey Medical (DERM) & Maruho Ink Deal for Qbrexza Asia Rights (Zacks)

Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Maraoui Claude	President & CEO	Aug 25 '25	Option Exercise	0.07	1,250,000	81,250	2,397,590	Aug 26 09:54 PM
Maraoui Claude	President & CEO	May 02 '25	Sale	6.84	4,834	33,065	2,348,313	May 05 05:34 PM
Benesch Joseph	CFO	May 02 '25	Sale	6.84	2,409	16,478	203,557	May 05 05:34 PM
Alloush Ramsey	COO	May 02 '25	Sale	6.84	2,857	19,542	504,817	May 05 05:31 PM
Maraoui Claude	President & CEO	Mar 11 '25	Sale	5.01	49,271	246,848	2,003,147	Mar 11 07:53 PM
Maraoui Claude	President & CEO	Mar 06 '25	Sale	5.04	25,551	128,777	2,067,323	Mar 10 06:21 PM
Maraoui Claude	President & CEO	Mar 07 '25	Sale	5.01	14,905	74,674	2,052,418	Mar 10 06:21 PM
Maraoui Claude	President & CEO	Mar 04 '25	Sale	5.04	28,901	145,661	2,111,021	Mar 05 07:53 PM
Maraoui Claude	President & CEO	Mar 03 '25	Sale	5.19	23,508	122,007	2,139,922	Mar 05 07:53 PM
Maraoui Claude	President & CEO	Mar 05 '25	Sale	5.13	18,147	93,094	2,092,874	Mar 05 07:53 PM
Benesch Joseph	CFO	Feb 21 '25	Sale	5.19	1,365	7,084	45,966	Feb 24 04:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Journey Medical Corp

Upgrade your FINVIZ experience